Biologically based dose-response model for liver tumors induced by trichloroethylene.

The existing extensive laboratory data on trichloroethylene (TCE) and its two metabolites, dichloroacetic (DCA) and trichloroacetic (TCA), are used to explore the relationship among these three compounds. Under the hypothesis that these compounds induce liver tumors in mice through promotion of preexisting initiated cells, it is demonstrated that DCA alone could be responsible for all the response of carcinomas in liver of B6CF(1) mice. The focus of this paper is on how a plausible biological assumption could impact on low-dose risk estimates, rather than on the risk estimate per se. The findings suggest that low-dose risk estimates to humans would be overestimated unless the different background rates between mice and humans are properly accounted for.

[1]  M. A. Pereira,et al.  The carcinogenicity of trichloroethylene and its metabolites, trichloroacetic acid and dichloroacetic acid, in mouse liver. , 1987, Toxicology and applied pharmacology.

[2]  S. Moolgavkar,et al.  Two-event models for carcinogenesis: incidence curves for childhood and adult tumors☆ , 1979 .

[3]  A. Deangelo,et al.  Advances in research on carcinogenic and genotoxic by-products of chlorine disinfection: chlorinated hydroxyfuranones and chlorinated acetic acids. , 1993, Annali dell'Istituto Superiore di Sanità.

[4]  S. Nasim,et al.  Ras oncogene activation during hepatocarcinogenesis in B6C3F1 male mice by dichloroacetic and trichloroacetic acids. , 1995, Carcinogenesis.

[5]  W Farland,et al.  Incorporating cell proliferation in quantitative cancer risk assessment: approaches, issues, and uncertainties. , 1991, Progress in clinical and biological research.

[6]  R. Bull,et al.  Differences in phenotype and cell replicative behavior of hepatic tumors induced by dichloroacetate (DCA) and trichloroacetate (TCA). , 1997, Toxicology and applied pharmacology.

[7]  R J Bull,et al.  Liver tumor induction in B6C3F1 mice by dichloroacetate and trichloroacetate. , 1990, Toxicology.

[8]  K S Crump,et al.  Use of mechanistic models to estimate low-dose cancer risks. , 1994, Risk analysis : an official publication of the Society for Risk Analysis.

[9]  H J Clewell,et al.  Development of a physiologically based pharmacokinetic model of trichloroethylene and its metabolites for use in risk assessment. , 2000, Environmental health perspectives.

[10]  S H Moolgavkar,et al.  Mutation and cancer: a model for human carcinogenesis. , 1981, Journal of the National Cancer Institute.

[11]  L. Hanin,et al.  A nonidentifiability aspect of the two-stage model of carcinogenesis. , 1996, Risk analysis : an official publication of the Society for Risk Analysis.

[12]  L. Ellwein,et al.  Cell growth dynamics in long-term bladder carcinogenesis. , 1988, Toxicology letters.

[13]  R J Bull,et al.  Mode of action of liver tumor induction by trichloroethylene and its metabolites, trichloroacetate and dichloroacetate. , 2000, Environmental health perspectives.

[14]  E G Luebeck,et al.  Interpretation of labeling indices in the presence of cell death. , 1992, Carcinogenesis.

[15]  W. Y. Tan,et al.  Stochastic modeling of carcinogenesis: Some new insights , 1998 .

[16]  L. Ellwein,et al.  Proliferative and genotoxic cellular effects in 2-acetylaminofluorene bladder and liver carcinogenesis: biological modeling of the ED01 study. , 1990, Toxicology and applied pharmacology.